Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Biological Activity of SAR405838 in Patients With Advanced Cancer

NCT01636479 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01636479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01636479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Biological Activity of SAR405838 in Patients With Advanced Cancer
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Completed
Start date
July 13, 2012
Completion date
March 5, 2018
Enrollment
77 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm malignant